Synthetic Biology & Biomanufacturing

Synthetic biology has matured from artisanal pathway construction into a design-build-test-learn discipline backed by AI-guided enzyme engineering and high-throughput strain screening. GSBG 2027 will examine cell-free protein synthesis platforms (Sutro, Nuclera), Ginkgo Bioworks-style automated foundries, and the use of generative models like ESM3 and ProGen to design novel biosynthetic enzymes. Sessions will cover continuous biomanufacturing, perfusion bioreactor scale-up for mRNA and AAV production, and the rapid expansion of precision fermentation for recombinant proteins, alternative proteins, and cultivated meat.